The drug is intended to help control high blood sugar when paired with diet and exercise.
The tablets are a generic equivalent of Raleigh, N.C.-based Santarus’ Glumetza tablets, which post annual sales of about $1.2 billion in the United States.
Mumbai, India-based Sun Pharmaceuticals expects to launch the tablets within the next few weeks.
More articles on the drug market:
FDA grants priority review status to muscular dystrophy drug
FDA seeks to increase access to Naloxone
Online market for illegal drugs skyrockets: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
